{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-041030","form_type":"8-K","ticker":"FRMM","cik":"0001690080","company_name":"FORUM MARKETS Inc","filed_at":"2024-05-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.620316+00:00","generated_at":"2026-06-02T06:24:27.430992+00:00","sec_items":["1.01","5.02","1.02","8.01","9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"180 Life Sciences CEO James Woody resigns; Blair Jordan named Interim CEO","bullets":["CEO James Woody resigned May 7; receives $50K cash, 25K fully-vested shares, contingency bonus of $50K.","CSO Jonathan Rothbard resigned; gets $200 cash, then consulted at $150/hr for 6 months.","Executive Chairman Lawrence Steinman forgave all accrued compensation; stepped down to board member.","Blair Jordan appointed Interim CEO via consulting firm at $216K/yr plus $250K change-of-control bonus.","Board set non-executive comp: $50K annual retainer, $15K committee chair, $25K for Strategy Committee."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-041030","json":"https://secwatch.observer/filing/0001213900-24-041030.json","markdown":"https://secwatch.observer/filing/0001213900-24-041030.md","text":"https://secwatch.observer/filing/0001213900-24-041030.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1690080/000121390024041030/0001213900-24-041030-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1690080/000121390024041030/ea0205589-8k_180lifesci.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T06:24:27.430992+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4e6247e16f","claim":"Dr. Jonathan Rothbard resigned as Chief Scientific Officer at FORUM MARKETS Inc.","evidence_excerpt":"On May 7, 2024, Dr. Jonathan Rothbard resigned as Chief Scientific Officer of the Company effective the same date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1690080/000121390024041030/0001213900-24-041030-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Scientific Officer"}],"fact_type":"executive_change"},{"claim_id":"61173f27a0","claim":"Dr. James N. Woody resigned as Chief Executive Officer (Principal Executive Officer) at FORUM MARKETS Inc.","evidence_excerpt":"On May 7, 2024, Dr. James N. Woody resigned as Chief Executive Officer (Principal Executive Officer), and as a member of the Board of Directors, of 180 Life Sciences Corp. (the “ Company ”, “ we ” and “ us ”) effective the same date","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1690080/000121390024041030/0001213900-24-041030-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Executive Officer (Principal Executive Officer)"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}